Patient Demographics: Age and Gender in BTK Inhibitor Treatment

added blog Health

2024-11-10 18:44:23 -

The use of BTK inhibitors in treating B-cell malignancies and autoimmune diseases spans a broad spectrum of patient demographics, including variations in age and gender. Understanding these demographics is critical for optimizing treatment outcomes and identifying which populations benefit most from these therapies. In terms of age, BTK inhibitors therapies are primarily used in older adults,...

0 Comments 0 Shares 167 Views 0 Reviews